Buffett buys remainder of Israel’s Iscar for $2.05b

US billionaire buys remaining 20% of the Iscar Metalworking Company seven years after snatching up 80% of the company.

May 1, 2013 18:33
2 minute read.
Berkshire Hathaway CEO Warren Buffett

Warren Buffett 370. (photo credit: REUTERS)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Warren Buffett, the oracle of Omaha, has once again seen a profitable future in Israel through his crystal ball.

Buffett’s Berkshire Hathaway announced that it purchased the last 20 percent of the Iscar Metalworking Company on Wednesday, seven years after making its first ever international investment when it snatched up the first 80 percent of the Israeli company.

Be the first to know - Join our Facebook page.

The hefty price tag indicates that IMC, the entirety of which was valued at $5 billion during the first transaction, has doubled in value since.

“As you can surmise from the price we’re paying for the remaining interest, IMC has enjoyed very significant growth over the last seven years, and we are delighted to acquire the portion of the company that was retained by the Wertheimer family when IMC first became a member of the Berkshire group of companies,” Buffett said.

IMC chairman Eitan Wertheimer praised the sale.

“We are very pleased that IMC has found a permanent home in Berkshire Hathaway, which fully appreciates the unique nature of the global Israeli enterprise that we have created, and that is committed to remaining true to that heritage in every way, building on and continuing our historic success and special culture,” he said.

Though Iscar, located in Tefen in Israel’s North, is the largest company in the IMC group, it also has facilities in the United States, Korea, Brazil, China, Germany, India, Italy and Japan.


“We are confident that being part of the Berkshire family will continue to help us strengthen our position worldwide and maintain the phenomenal growth that we have experienced over the past 60 years,” added IMC President and CEO Jacob Harpaz.

The transaction is expected to bring in considerable tax revenue, which will be welcome news to Finance Minister Yair Lapid, who is struggling to bring down the deficit for the 2013-2014 state budget.

“It’s an Israeli resident and a considerable transaction, so there’s no reason why there shouldn’t be considerable taxes collected,” a spokesman for the Tax Authority said, but pointed out that the lack of specific details of the deal precluded precise estimations of how much tax revenue.

According to Globes, the $4b. transaction in 2006 yielded a $1b. tax windfall for the state, and media speculated that the latest transaction could bring in between NIS 1b. and NIS 1.8b.

The influx of dollars may present a challenge to the Bank of Israel, however. In recent weeks, it has struggled to keep the shekel from getting too strong on the world market, buying up dollars in the foreign exchange market as the exchange rate fell stubbornly below NIS 3.6 to the dollar.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection